美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
71205-380-60	71205-380	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20200106	N/A	ANDA	ANDA065259	Proficient Rx LP	CEFDINIR	250 mg/5mL	60 mL in 1 BOTTLE (71205-380-60)
71205-380-00	71205-380	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20210603	N/A	ANDA	ANDA065259	Proficient Rx LP	CEFDINIR	250 mg/5mL	100 mL in 1 BOTTLE (71205-380-00)
68180-722-05	68180-722	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20200522	N/A	ANDA	ANDA065259	Lupin Pharmaceuticals, Inc.	CEFDINIR	125 mg/5mL	100 mL in 1 BOTTLE (68180-722-05)
68180-722-04	68180-722	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20200522	N/A	ANDA	ANDA065259	Lupin Pharmaceuticals, Inc.	CEFDINIR	125 mg/5mL	60 mL in 1 BOTTLE (68180-722-04)
68180-723-04	68180-723	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20200522	N/A	ANDA	ANDA065259	Lupin Pharmaceuticals, Inc.	CEFDINIR	250 mg/5mL	60 mL in 1 BOTTLE (68180-723-04)
68180-723-05	68180-723	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20200522	N/A	ANDA	ANDA065259	Lupin Pharmaceuticals, Inc.	CEFDINIR	250 mg/5mL	100 mL in 1 BOTTLE (68180-723-05)
68071-3403-1	68071-3403	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20230516	N/A	ANDA	ANDA065259	NuCare Pharmaceuticals,Inc.	CEFDINIR	250 mg/5mL	100 mL in 1 BOTTLE (68071-3403-1)
68071-3609-6	68071-3609	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20240625	N/A	ANDA	ANDA065259	NuCare Pharmaceuticals,Inc.	CEFDINIR	125 mg/5mL	60 mL in 1 BOTTLE (68071-3609-6)
76420-328-01	76420-328	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20250419	N/A	ANDA	ANDA065259	Asclemed USA, Inc.	CEFDINIR	250 mg/5mL	100 mL in 1 BOTTLE (76420-328-01)
76420-328-60	76420-328	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20250419	N/A	ANDA	ANDA065259	Asclemed USA, Inc.	CEFDINIR	250 mg/5mL	60 mL in 1 BOTTLE (76420-328-60)
68071-3806-1	68071-3806	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20250306	N/A	ANDA	ANDA065259	NuCare Pharmaceuticals, Inc.	CEFDINIR	125 mg/5mL	100 mL in 1 BOTTLE (68071-3806-1)
76420-327-60	76420-327	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20250419	N/A	ANDA	ANDA065259	Asclemed USA, Inc.	CEFDINIR	125 mg/5mL	60 mL in 1 BOTTLE (76420-327-60)
50090-3723-0	50090-3723	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20181025	N/A	ANDA	ANDA065259	A-S Medication Solutions	CEFDINIR	250 mg/5mL	100 mL in 1 BOTTLE (50090-3723-0)
76420-327-01	76420-327	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20250419	N/A	ANDA	ANDA065259	Asclemed USA, Inc.	CEFDINIR	125 mg/5mL	100 mL in 1 BOTTLE (76420-327-01)
72189-043-32	72189-043	HUMAN PRESCRIPTION DRUG	CEFDINIR	CEFDINIR	POWDER, FOR SUSPENSION	ORAL	20191125	N/A	ANDA	ANDA065259	DIRECT RX	CEFDINIR	250 mg/5mL	5 mL in 1 BOTTLE (72189-043-32)
50090-6171-0	50090-6171	HUMAN PRESCRIPTION DRUG	Cefdinir	Cefdinir	POWDER, FOR SUSPENSION	ORAL	20221014	N/A	ANDA	ANDA065259	A-S Medication Solutions	CEFDINIR	250 mg/5mL	60 mL in 1 BOTTLE (50090-6171-0)